Myeloid miR-155 deficiency exacerbates viral encephalitis by hindering M1 macrophage polarization and NLRP3 inflammasome activation
Background
Neurotropic viruses like Japanese encephalitis virus (JEV) pose a significant global health threat, causing severe CNS inflammation and high mortality. Effective immune responses are crucial for viral clearance and limiting neurological damage, yet the precise cellular and molecular mechanisms governing these responses in the brain remain incompletely understood. Specifically, the role of microRNAs, such as miR-155, in orchestrating immune cell functions during viral neuroinflammation, particularly within distinct immune cell subsets, has been unclear. Understanding these specific regulatory pathways could unlock novel therapeutic strategies.
Study Design
Researchers generated conditional miR-155 knockout mice with cell type-specific deletion in myeloid cells, dendritic cells (DCs), T cells, or B cells using Cre-LoxP technology. Following JEV infection, they assessed survival rates, viral burden in tissues, type I interferon responses, M1 macrophage polarization, and NLRP3 inflammasome activation. Downstream targets of miR-155 were identified, and the effects of NLRP3 inhibition or IL-1α/IL-1β neutralization were evaluated to dissect the underlying mechanisms. This approach allowed for precise attribution of miR-155's role to specific immune cell populations.
Results
Myeloid cell-specific deletion of miR-155, but not its deletion in other immune cell types, significantly increased susceptibility to JEV infection and exacerbated neuroinflammation. This phenotype was consistently associated with elevated viral burdens in both lymphoid and CNS tissues. Critically, the deficiency led to impaired type I interferon responses, defective M1 macrophage polarization, and reduced NLRP3 inflammasome activation. Mechanistically, Peli1, Jarid2, and Bcl6 were identified as key downstream targets of miR-155 that regulate M1 polarization and NLRP3 inflammasome activity. Further validation showed that pharmacological inhibition of NLRP3 or neutralization of IL-1α and IL-1β further worsened disease severity and suppressed M1 polarization, underscoring the importance of this pathway.
Myeloid cell-specific miR-155 is essential for protective immunity against JEV by promoting M1 macrophage polarization and NLRP3 inflammasome activation.
Key Findings
- Myeloid cell-specific miR-155 deletion significantly increased susceptibility to JEV infection.
- Myeloid miR-155 deficiency exacerbated neuroinflammation and elevated viral burdens in
CNStissues. - Deficiency led to impaired
M1 macrophage polarizationand reducedNLRP3 inflammasomeactivation. Peli1,Jarid2, andBcl6were identified as key miR-155 targets regulatingM1 polarizationandNLRP3activity.- Inhibiting
NLRP3or neutralizingIL-1α/IL-1βworsened disease and suppressedM1 polarization.
Why It Matters
This study significantly advances our understanding of how miR-155 in myeloid cells, particularly macrophages, orchestrates protective immune responses during neurotropic viral infections. Targeting myeloid miR-155 or its downstream pathways could offer a novel therapeutic strategy for viral encephalitis, potentially by enhancing M1 macrophage polarization and NLRP3 inflammasome activation to improve viral clearance and reduce neuroinflammation. For biohackers and clinicians, this research highlights the critical role of specific immune cell subsets and microRNAs in CNS immunity, suggesting future interventions might focus on precision immune modulation rather than broad immunosuppression. While preclinical, it lays groundwork for developing compounds that modulate these specific pathways to combat severe viral neuroinflammation.
neuroinflammation
japanese-encephalitis-virus
mir-155
myeloid-cells
macrophages
nlrp3-inflammasome